MicroRNAs and Possible Role in Pituitary Adenoma

Maria Chiara Zatelli; Ettore C. degli Uberti

doi:10.1055/s-0028-1096125

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2008; 26(6): 453-460
DOI: 10.1055/s-0028-1096125

MicroRNAs and Possible Role in Pituitary Adenoma

Maria Chiara Zatelli¹ , Ettore C. degli Uberti¹

¹Section of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Ferrara, Italy

Abstract

ABSTRACT

This review reports the current knowledge of microRNA (miRNA) expression in pituitary adenomas, focusing on recent microarray data. Moreover, a discussion is provided concerning the possible role of validated and putative targets of the most dysregulated miRNA in pituitary adenoma pathogenesis.

KEYWORDS

MicroRNA - pituitary - pituitary adenoma

Volltext

Referenzen

REFERENCES

1 Bartel D P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116 281-297
2 Kloosterman W P, Plasterk R H. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006; 11 441-450
3 Du T, Zamore P D. microPrimer: the biogenesis and function of microRNA. Development. 2005; 132 4645-4652
4 Zeng Y. Principles of micro-RNA production and maturation. Oncogene. 2006; 25 6156-6162
5 He L, Hannon G J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5 522-531
6 Bushati N, Cohen S M. microRNA functions. Annu Rev Cell Dev Biol. 2007; 23 175-205
7 Vasudevan S, Tong Y, Steitz J A. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007; 318 1931-1934
8 Filipowicz W, Bhattacharyya S N, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet. 2008; 9 102-114
9 Esau C, Kang X, Peralta E et al.. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem. 2004; 279 52361-52365
10 Poy M N, Eliasson L, Krutzfeldt J et al.. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004; 432 226-230
11 Cuellar T L, McManus M T. MicroRNAs and endocrine biology. J Endocrinol. 2005; 187 327-332
12 Bak M, Silahtaroglu A, Møller M et al.. MicroRNA expression in the adult mouse central nervous system. RNA. 2008; 14 432-444
13 Farh K K, Grimson A, Jan C et al.. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science. 2005; 310 1817-1821
14 Landgraf P, Rusu M, Sheridan R et al.. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129 1401-1414
15 Vadstrup S. The adaptation of TSH secretion to autonomy in non-toxic goiter may be based-on active regulation of set-point and sensitivity of central TSH-receptors, perhaps by the microRNA (MIR) gene. Med Hypotheses. 2006; 67 588-591
16 Bates A S, Farrell W E, Bicknell E J et al.. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab. 1997; 82 818-824
17 Fan X, Paetau A, Aalto Y et al.. Gain of chromosome 3 and loss of 13q are frequent alterations in pituitary adenomas. Cancer Genet Cytogenet. 2001; 128 97-103
18 Knuutila S, Aalto Y, Autio K et al.. DNA copy number losses in human neoplasms. Am J Pathol. 1999; 155 683-694
19 Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict W F, Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (Rb) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor uppressor gene other than Rb. Cancer Res. 1995; 55 1613-1616
20 Calin G A, Dumitru C D, Shimizu M et al.. Frequent deletions and down-regulation ofmicro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukaemia. Proc Natl Acad Sci U S A. 2002; 99 15524-15529
21 Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli M C, degli Uberti E C. miR-15a and miR-16–1 down-regulation in pituitary adenomas. J Cell Physiol. 2005; 204 280-285
22 Cimmino A, Calin G A, Fabbri M et al.. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005; 103 13944-13949
23 Wang D G, Johnston C F, Atkinson A B, Heaney A P, Mirakhur M, Buchanan K D. Expression of bcl-2 oncoprotein in pituitary tumours: comparison with cmyc. J Clin Pathol. 1996; 49 795-797
24 Ibba M, Soll D. Aminoacyl-tRNA synthesis. Annu Rev Biochem. 2000; 69 617-650
25 Quevillon S, Robinson J C, Berthonneau E, Siatecka M, Mirande M. Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of protein–protein interactions and characterization of a core protein. J Mol Biol. 1999; 285 183-195
26 Shalak V, Kaminska M, Mitnacht-Kraus R, Vandenabeele P, Clauss M, Mirande M. The EMAPII cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPII component. J Biol Chem. 2001; 276 23769-23776
27 Schwarz M A, Kandel J, Brett J et al.. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J Exp Med. 1999; 190 341-343
28 Bottoni A, Vignali C, Piccin D et al.. Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. J Cell Physiol. 2007; 212 293-297
29 Bottoni A, Zatelli M C, Ferracin M et al.. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol. 2007; 210 370-377
30 Liu C G, Calin G A, Meloon B et al.. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A. 2004; 101 9740-9744
31 Volinia S, Calin G A, Liu C G et al.. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103 2257-2261
32 Pagotto U, Arzberger T, Theodoropoulou M et al.. The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas. Cancer Res. 2000; 60 6794-6799
33 Spengler D, Villalba M, Hoffmann A et al.. Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain. EMBO J. 1997; 16 2814-2825
34 Abdollahi A, Bao R, Hamilton T C. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein. Oncogene. 1999; 18 6477-6487
35 Pagotto U, Arzberger T, Ciani E et al.. Inhibition of Zac1, a new gene differentially expressed in the anterior pituitary, increases cell proliferation. Endocrinology. 1999; 140 987-996
36 Theodoropoulou M, Zhang J, Laupheimer S et al.. Octreotide, a somatostatin analogue mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression. Cancer Res. 2006; 66 1576-1582
37 Cheng A M, Byrom M W, Shelton J, Ford L P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005; 33 1290-1297
38 Iorio M V, Ferracin M, Liu C G et al.. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65 7065-7070
39 Takamizawa J, Konishi H, Yanagisawa K et al.. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004; 64 3753-3756
40 Sempere L F, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004; 5 R13
41 Ciafre S A, Galardi S, Mangiola A et al.. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005; 334 1351-1358
42 Seitz H, Youngson N, Lin S P et al.. Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. Nat Genet. 2003; 34 261-262
43 Youngson N, Kocialkowski S, Peel N, Ferguson-Smith A C. A small family of sushi-class retrotransposon derived genes in mammals and their relation to genomic imprinting. J Mol Evol. 2005; 61 481-490
44 Georgiades P, Watkins M, Surani M A, Ferguson-Smith A C. Parental origin-specific developmental defects in mice with uniparental disomy for chromosome 12. Development. 2000; 127 4719-4728
45 Reik W, Constancia M, Fowden A et al.. Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J Physiol. 2003; 547 35-44
46 Asa S L, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev. 1998; 19 798-827
47 Cheng A M, Byrom M W, Shelton J, Ford L P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005; 33 1290-1297
48 Hebert C, Norris K, Scheper M A, Nikitakis N, Sauk J J. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer. 2007; 6 5-16
49 Reeves R, Nissen M S. The A-T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem. 1990; 265 8573-8582
50 Thanos D, Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell. 1995; 83 1091-1100
51 Fedele M, Battista S, Manfioletti G, Croce C M, Giancotti V, Fusco A. Role of the high mobility group A proteins in human lipomas. Carcinogenesis. 2001; 22 1583-1591
52 Fedele M, Battista S, Kenyon L et al.. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene. 2002; 21 3190-3198
53 Finelli P, Pierantoni G M, Giardino D et al.. The high mobility group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res. 2002; 62 2398-2405
54 Fedele M, Pierantoni G M, Visone R, Fusco A. Critical role of the HMGA2 gene in pituitary adenomas. Cell Cycle. 2006; 5 2045-2048
55 McCabe C J, Boelaert K, Tannahill L A et al.. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab. 2002; 87 4238-4244
56 Niveiro M, Aranda F I, Peiró G, Alenda C, Picó A. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Hum Pathol. 2005; 36 1090-1095
57 Onofri C, Theodoropoulou M, Losa M et al.. Localization of vascular endoelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours. J Endocrinol. 2006; 191 249-261
58 Macleod R M, Thorner M O, Scapagnini U. Basic and Clinical Correlates. Padova, Italy; Liviana Press 1995: 641-653
59 Zatelli M C, Piccin D, Vignali C et al.. Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. Endocr Relat Cancer. 2007; 14 91-102

Prof. Ettore C degli Uberti

Section of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara

Via Savonarola 9, 44100 Ferrara, Italy

eMail: dut@unife.it